- Home
- APLT vs CECO Comparison
APLT vs CECO Comparison
Compare APLT & CECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- CECO
- Stock Information
- Founded
- APLT 2016
- CECO 1966
- Country
- APLT United States
- CECO United States
- Employees
- APLT N/A
- CECO N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- CECO Pollution Control Equipment
- Sector
- APLT Health Care
- CECO Industrials
- Exchange
- APLT Nasdaq
- CECO Nasdaq
- Market Cap
- APLT 52.9M
- CECO 957.2M
- IPO Year
- APLT 2019
- CECO N/A
- Fundamental
- Price
- APLT $0.33
- CECO $30.00
- Analyst Decision
- APLT Buy
- CECO Strong Buy
- Analyst Count
- APLT 7
- CECO 5
- Target Price
- APLT $6.10
- CECO $36.00
- AVG Volume (30 Days)
- APLT 2.3M
- CECO 284.5K
- Earning Date
- APLT 08-06-2025
- CECO 07-29-2025
- Dividend Yield
- APLT N/A
- CECO N/A
- EPS Growth
- APLT N/A
- CECO 273.86
- EPS
- APLT N/A
- CECO 1.30
- Revenue
- APLT $265,000.00
- CECO $608,298,000.00
- Revenue This Year
- APLT $1,768.13
- CECO $32.90
- Revenue Next Year
- APLT $292.85
- CECO $9.01
- P/E Ratio
- APLT N/A
- CECO $23.01
- Revenue Growth
- APLT N/A
- CECO 8.89
- 52 Week Low
- APLT $0.30
- CECO $17.57
- 52 Week High
- APLT $10.62
- CECO $35.16
- Technical
- Relative Strength Index (RSI)
- APLT 43.25
- CECO 61.50
- Support Level
- APLT $0.30
- CECO $28.01
- Resistance Level
- APLT $0.36
- CECO $30.56
- Average True Range (ATR)
- APLT 0.03
- CECO 1.14
- MACD
- APLT -0.00
- CECO -0.06
- Stochastic Oscillator
- APLT 22.22
- CECO 85.19
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About CECO CECO Environmental Corp.
CECO Environmental Corp serves the energy, industrial, and other niche markets. The company operates through the Engineered Systems segment that serves the power generation, refinery, water/wastewater, and midstream oil and gas markets, and Industrial Process Solutions segment, which serves the broad industrial air pollution control, beverage can, fluid handling, electric vehicle production, food and beverage, semi-conductor, process filtration, pharmaceutical, petrochemical, wastewater treatment, wood manufacturing, desalination, and aquaculture markets. The majority of revenue is earned from the Engineered Systems Segment.